Dr Brendan Shaw
In January 2010 Brendan Shaw was appointed Chief Executive of Medicines Australia.
Prior to this, Brendan led the Health Policy and Research team at Medicines Australia, representing the industry on the Pharmaceuticals Benefits Pricing Authority, the Access to Medicines Working Group, and for two years he was the industry member of the Economic Sub-Committee of the Pharmaceuticals Benefits Advisory Committee.
has been instrumental in guiding the pharmaceutical industry through reforms to the Pharmaceuticals Benefits Scheme, the Pharmaceuticals Benefits Advisory Committee process and the Therapeutic Goods
has driven Medicines Australia's
research program, and has been pivotal in Medicines Australia's
contribution to the international debate on health technology assessment.
Prior to taking up his appointment with Medicines Australia in January 2004, Brendan was adviser to then Shadow Minister for Innovation, Industry and Trade, Dr Craig Emerson MP.
has previously worked in academia, consulting and the Australian Government in the areas of economic development, innovation, industry analysis and public policy.
He has an honours degree in economics from the University of Queensland and a PhD in management from Monash University.